- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有156家主力机构披露2025-12-31报告期持股数据，持仓量总计2655.21万股，占流通A股4.72%
- 波段诊断：
-
技术面诊股
诊断结果：5.8技术面打败了57%的股票
技术面评分前10的股票
近期的平均成本为14.88元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为14.88元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.88","date":1776154338,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2026.04.15","stock":"-0.67","trade":null,"ind":"-0.97"},{"date":"2026.04.14","stock":"2.74","trade":null,"ind":"1.61"},{"date":"2026.04.13","stock":"-1.42","trade":null,"ind":"0.69"},{"date":"2026.04.10","stock":"1.23","trade":null,"ind":"2.24"},{"date":"2026.04.09","stock":"-2.14","trade":null,"ind":"-0.33"},{"date":"2026.04.08","stock":"3.47","trade":null,"ind":"4.79"},{"date":"2026.04.07","stock":"1.12","trade":null,"ind":"0.36"},{"date":"2026.04.03","stock":"-2.86","trade":null,"ind":"-0.99"},{"date":"2026.04.02","stock":"-1.48","trade":null,"ind":"-1.60"},{"date":"2026.04.01","stock":"4.41","trade":null,"ind":"1.70"},{"date":"2026.03.31","stock":"-0.76","trade":null,"ind":"-1.81"},{"date":"2026.03.30","stock":"-0.48","trade":null,"ind":"-0.25"},{"date":"2026.03.27","stock":"3.21","trade":null,"ind":"1.13"},{"date":"2026.03.26","stock":"-0.07","trade":null,"ind":"-1.41"},{"date":"2026.03.25","stock":"0.57","trade":null,"ind":"1.95"},{"date":"2026.03.24","stock":"2.35","trade":null,"ind":"1.43"},{"date":"2026.03.23","stock":"-6.46","trade":null,"ind":"-3.76"},{"date":"2026.03.20","stock":"-3.45","trade":null,"ind":"-0.25"},{"date":"2026.03.19","stock":"-6.63","trade":null,"ind":"-2.02"},{"date":"2026.03.18","stock":"2.22","trade":null,"ind":"1.05"},{"date":"2026.03.17","stock":"0.64","trade":null,"ind":"-1.87"}]
东富龙,深证成指,医疗器械指数
压力支撑
该股压力位为14.93元，支撑位为14.72元。
[{"text":"\u538b\u529b\u4f4d","value":"14.93","date":1776182400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.72","date":1776182400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.5资金面打败了35%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月15日 20:31
| 机构今日流向(万元) | -508.54 | 机构5日流向(万元) | -3918.77 |
| 机构10日流向(万元) | -3812.57 | 机构20日流向(万元) | -7519.50 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少7148.56万股，其中基金净减仓10家，主力净增仓87家，暂未发现中长期投资价值。
截止2025-12-31，共156家主力机构（基金156家），持仓量总计2655.21万股，占流通A股4.72%
其中，基金持仓与2025-06-30相比：
增仓：13家 ，增持 70.03万股
减仓：23家 ，减持 90.00万股
新出现在主力名单中：114家 ，持有1426.39万股
从主力名单中消失：27家 ，原持有8554.98万股
其中，基金持仓与2025-06-30相比：
增仓：13家 ，增持 70.03万股
减仓：23家 ，减持 90.00万股
新出现在主力名单中：114家 ，持有1426.39万股
从主力名单中消失：27家 ，原持有8554.98万股
消息面诊股
诊断结果：5.5消息面打败了32%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 东富龙：4月14日获融资买入1056.36万元
2026-04-15 - 东富龙：4月13日获融资买入804.95万元
2026-04-14 - 东富龙：4月10日获融资买入764.57万元
2026-04-13 - 东富龙：4月9日获融资买入692.71万元
2026-04-10 - 东富龙：4月8日获融资买入773.10万元
2026-04-09 - 东富龙：4月7日获融资买入240.16万元
2026-04-08 - 东富龙：4月3日获融资买入375.03万元
2026-04-07 - 东富龙：4月2日获融资买入763.38万元
2026-04-03 - 东富龙：4月1日获融资买入910.93万元
2026-04-02 - 东富龙：3月31日获融资买入533.82万元
2026-04-01
消息列表
| 一般消息 | 高管变动 | 不再担任 | 2026-02-03 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-01-17 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 利好 | 分红转增 | 10派0.3元(含税) | 2025-08-28 |
| 一般消息 | 高管变动 | 增强公司可持续发展能力 | 2025-08-27 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派0.76元(含税) | 2025-04-25 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了46%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.04.15","price":"-0.97","value":null},{"date":"2026.04.14","price":"1.61","value":null},{"date":"2026.04.13","price":"0.69","value":null},{"date":"2026.04.10","price":"2.24","value":null},{"date":"2026.04.09","price":"-0.33","value":null},{"date":"2026.04.08","price":"4.79","value":null},{"date":"2026.04.07","price":"0.36","value":null},{"date":"2026.04.03","price":"-0.99","value":null},{"date":"2026.04.02","price":"-1.60","value":null},{"date":"2026.04.01","price":"1.70","value":null},{"date":"2026.03.31","price":"-1.81","value":null},{"date":"2026.03.30","price":"-0.25","value":null},{"date":"2026.03.27","price":"1.13","value":null},{"date":"2026.03.26","price":"-1.41","value":null},{"date":"2026.03.25","price":"1.95","value":null},{"date":"2026.03.24","price":"1.43","value":null},{"date":"2026.03.23","price":"-3.76","value":null},{"date":"2026.03.20","price":"-0.25","value":null},{"date":"2026.03.19","price":"-2.02","value":null},{"date":"2026.03.18","price":"1.05","value":null},{"date":"2026.03.17","price":"-1.87","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 海泰新光 | 74.39% | -1.47% | 6.0分 |
| 2 | 九安医疗 | 38.68% | -13.71% | 5.0分 |
| 3 | 力诺药包 | 32.06% | -0.63% | 5.3分 |
| 4 | 奥美医疗 | 21.26% | 10.44% | 5.0分 |
| 5 | 济民健康 | 18.25% | -1.97% | 5.0分 |
| 6 | 健信超导 | 18.04% | 15.97% | 6.0分 |
| 8 | 康众医疗 | 11.91% | -2.21% | 4.9分 |
| 10 | 英诺特 | 11.23% | 19.46% | 5.9分 |
| 12 | 惠泰医疗 | 8.01% | -2.27% | 5.7分 |
| 14 | 国发股份 | 5.96% | -3.03% | 3.9分 |
| 16 | 凯普生物 | 5.75% | 0.87% | 4.7分 |
| 18 | 艾德生物 | 5.11% | 0.57% | 5.0分 |
| 20 | 春立医疗 | 4.47% | 1.56% | 5.8分 |
| 22 | 理邦仪器 | 2.69% | 3.84% | 6.3分 |
| 24 | 福瑞医科 | 2.49% | -4.67% | 4.8分 |
| 26 | 赛诺医疗 | 2.37% | 1.80% | 5.2分 |
| 28 | 正川股份 | 1.51% | -0.25% | 4.7分 |
| 30 | 热景生物 | 0.23% | 1.73% | 3.7分 |
| 32 | 威高骨科 | -0.03% | -1.79% | 5.8分 |
| 34 | 东星医疗 | -0.11% | 0.04% | 4.2分 |
| 36 | 三鑫医疗 | -0.20% | -1.71% | 4.9分 |
| 38 | 安旭生物 | -0.51% | -0.36% | 4.5分 |
| 40 | 东方生物 | -0.73% | -1.29% | 4.8分 |
| 42 | 博拓生物 | -1.01% | 1.80% | 4.9分 |
| 44 | 利德曼 | -1.32% | -1.03% | 4.6分 |
| 46 | 海尔生物 | -1.46% | 2.63% | 5.1分 |
| 48 | 安图生物 | -1.77% | -1.52% | 5.2分 |
| 50 | 乐心医疗 | -1.91% | -0.22% | 5.0分 |
| 52 | 港通医疗 | -2.12% | -3.17% | 4.9分 |
| 54 | - | -2.17% | -1.26% | 分 |
| 56 | 美康生物 | -2.44% | 0.50% | 4.5分 |
| 58 | 天臣医疗 | -2.88% | 1.09% | 5.8分 |
| 60 | 万泰生物 | -3.08% | -1.67% | 4.3分 |
| 62 | 九强生物 | -3.28% | -0.33% | 4.4分 |
| 64 | 美好医疗 | -3.38% | -1.21% | 5.6分 |
| 66 | 万东医疗 | -3.43% | -2.33% | 4.8分 |
| 68 | 爱威科技 | -3.61% | -5.14% | 5.6分 |
| 70 | 戴维医疗 | -3.94% | -0.62% | 5.3分 |
| 72 | 普门科技 | -4.22% | 0.87% | 5.4分 |
| 74 | 冠昊生物 | -4.45% | -1.78% | 5.2分 |
| 76 | 中源协和 | -4.47% | -0.80% | 4.1分 |
| 78 | - | -4.69% | 4.00% | 分 |
| 80 | 麦克奥迪 | -4.72% | 1.84% | 5.0分 |
| 82 | 祥生医疗 | -4.76% | -1.23% | 4.8分 |
| 84 | 爱迪特 | -5.06% | -6.35% | 5.1分 |
| 86 | 华大智造 | -5.25% | -1.26% | 4.8分 |
| 88 | 赛科希德 | -5.41% | -4.58% | 4.9分 |
| 90 | 威高血净 | -5.63% | 0.45% | 6.0分 |
| 92 | 安必平 | -5.81% | -3.37% | 4.6分 |
| 94 | 蓝帆医疗 | -5.88% | -5.05% | 4.6分 |
| 96 | 心脉医疗 | -6.06% | -2.79% | 5.2分 |
| 98 | 阳普医疗 | -6.33% | -3.51% | 5.2分 |
| 100 | 昊海生科 | -6.48% | -2.47% | 5.5分 |
| 102 | 翔宇医疗 | -6.94% | -1.01% | 4.9分 |
| 104 | 振德医疗 | -7.00% | -5.24% | 5.5分 |
| 106 | 海利生物 | -7.04% | -3.85% | 3.8分 |
| 108 | 奕瑞科技 | -7.07% | -2.75% | 5.6分 |
| 110 | 迪瑞医疗 | -7.43% | -2.28% | 4.2分 |
| 112 | - | -7.59% | -1.95% | 分 |
| 114 | 尚荣医疗 | -8.24% | -4.17% | 5.2分 |
| 116 | 超研股份 | -8.86% | -4.11% | 5.3分 |
| 118 | - | -9.01% | -0.88% | 分 |
| 120 | 易瑞生物 | -9.25% | -1.06% | 4.9分 |
| 122 | 欧普康视 | -9.50% | -1.05% | 4.8分 |
| 124 | 迈瑞医疗 | -9.99% | -1.61% | 5.0分 |
| 126 | - | -10.57% | -0.64% | 分 |
| 128 | 济高发展 | -11.71% | -8.41% | 4.1分 |
| 130 | 新产业 | -11.92% | -4.05% | 4.9分 |
| 132 | - | -14.20% | -0.54% | 分 |
| 134 | - | -14.37% | -0.41% | 分 |
| 136 | 硕世生物 | -16.40% | -4.64% | 3.6分 |
| 138 | 东方海洋 | -19.44% | -3.79% | 4.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 86/242 ， 108/242。
[{"date":"2025-09-30","value":"1.68","vol":"2.98"},{"date":"2025-06-30","value":"0.59","vol":"2.34"},{"date":"2025-03-31","value":"0.26","vol":"1.16"},{"date":"2024-12-31","value":"2.47","vol":"0.56"},{"date":"2024-09-30","value":"1.94","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.68 | 0.59 | 0.26 | 2.47 | 1.94 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"30.85","vol":"51.74"},{"date":"2025-06-30","value":"28.92","vol":"52.05"},{"date":"2025-03-31","value":"24.45","vol":"51.42"},{"date":"2024-12-31","value":"29.25","vol":"52.52"},{"date":"2024-09-30","value":"29.49","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
30.85 | 28.92 | 24.45 | 29.25 | 29.49 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 38/242 ， 71/242。
[{"date":"2025-09-30","value":"6.14","vol":"0.26"},{"date":"2025-06-30","value":"6.01","vol":"-1.09"},{"date":"2025-03-31","value":"2.58","vol":"-0.12"},{"date":"2024-12-31","value":"-11.19","vol":"1.15"},{"date":"2024-09-30","value":"-19.32","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
6.14 | 6.01 | 2.58 | -11.19 | -19.32 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-13.86","vol":"-15.37"},{"date":"2025-06-30","value":"-59.71","vol":"-18.14"},{"date":"2025-03-31","value":"-68.87","vol":"-2.59"},{"date":"2024-12-31","value":"-67.66","vol":"-23.09"},{"date":"2024-09-30","value":"-73.82","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-13.86 | -59.71 | -68.87 | -67.66 | -73.82 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 54/242 ， 110/242。
[{"date":"2025-09-30","value":"0.28","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"},{"date":"2025-03-31","value":"0.09","vol":"0.08"},{"date":"2024-12-31","value":"0.39","vol":"0.36"},{"date":"2024-09-30","value":"0.27","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.28 | 0.18 | 0.09 | 0.39 | 0.27 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.77","vol":"1.66"},{"date":"2025-06-30","value":"0.52","vol":"1.12"},{"date":"2025-03-31","value":"0.26","vol":"0.55"},{"date":"2024-12-31","value":"1.03","vol":"2.32"},{"date":"2024-09-30","value":"0.69","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.77 | 0.52 | 0.26 | 1.03 | 0.69 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"3.71","vol":"14.74"},{"date":"2025-06-30","value":"22.10","vol":"15.17"},{"date":"2025-03-31","value":"-0.79","vol":"4.22"},{"date":"2024-12-31","value":"29.74","vol":"29.38"},{"date":"2024-09-30","value":"19.73","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 3.71 | 22.10 | -0.79 | 29.74 | 19.73 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"2.18","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.95","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.18 | - | 3.95 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/242 ， 7/242。
[{"date":"2025-09-30","value":"2.01","vol":"5.66"},{"date":"2025-06-30","value":"2.01","vol":"5.47"},{"date":"2025-03-31","value":"2.07","vol":"5.84"},{"date":"2024-12-31","value":"1.99","vol":"5.30"},{"date":"2024-09-30","value":"2.03","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.01 | 2.01 | 2.07 | 1.99 | 2.03 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.15","vol":"4.51"},{"date":"2025-06-30","value":"1.09","vol":"4.35"},{"date":"2025-03-31","value":"1.11","vol":"4.73"},{"date":"2024-12-31","value":"1.05","vol":"4.27"},{"date":"2024-09-30","value":"1.07","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.15 | 1.09 | 1.11 | 1.05 | 1.07 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 10/242 ， 13/242。
[{"date":"2025-09-30","value":"39.19","vol":"22.07"},{"date":"2025-06-30","value":"39.36","vol":"22.01"},{"date":"2025-03-31","value":"38.09","vol":"21.19"},{"date":"2024-12-31","value":"38.43","vol":"21.94"},{"date":"2024-09-30","value":"38.44","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
39.19 | 39.36 | 38.09 | 38.43 | 38.44 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.66","vol":"0.71"},{"date":"2025-06-30","value":"0.67","vol":"0.58"},{"date":"2025-03-31","value":"0.63","vol":"0.56"},{"date":"2024-12-31","value":"0.64","vol":"0.55"},{"date":"2024-09-30","value":"0.64","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.66 | 0.67 | 0.63 | 0.64 | 0.64 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"8.28","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.47","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.00","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.94","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]